271 related articles for article (PubMed ID: 25991065)
41. Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization.
Agiba AM; Abdel-Hamid S; Nasr M; Geneidi AS
Curr Drug Deliv; 2018 Feb; 15(2):267-277. PubMed ID: 28322163
[TBL] [Abstract][Full Text] [Related]
42. Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole.
Mugheirbi NA; Paluch KJ; Tajber L
Int J Pharm; 2014 Aug; 471(1-2):400-11. PubMed ID: 24879938
[TBL] [Abstract][Full Text] [Related]
43. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
[TBL] [Abstract][Full Text] [Related]
44. Tablet formulation of Famotidine-loaded P-gp inhibiting nanoparticles using PLA-g-PEG grafted polymer.
Mokhtar M; Gosselin PM; François-Xavier L; Hildgen P
Pharm Dev Technol; 2019 Feb; 24(2):211-221. PubMed ID: 29564944
[TBL] [Abstract][Full Text] [Related]
45. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
[TBL] [Abstract][Full Text] [Related]
46. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
47. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
48. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
49. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
50. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
51. Physicochemical, Pharmacodynamic and Pharmacokinetic Characterization of Soluplus Stabilized Nanosuspension of Tacrolimus.
Varshosaz J; Minayian M; Yazdekhasti S
Curr Drug Deliv; 2017; 14(4):521-535. PubMed ID: 27697037
[TBL] [Abstract][Full Text] [Related]
52. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
53. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
[TBL] [Abstract][Full Text] [Related]
54. Formulation and characterization study of itraconazole-loaded microparticles.
Segale L; Giovannelli L; Mannina P; Pattarino F
Pharm Dev Technol; 2015 Mar; 20(2):153-8. PubMed ID: 24219826
[TBL] [Abstract][Full Text] [Related]
55. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
[TBL] [Abstract][Full Text] [Related]
56. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
57. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
58. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
59. Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions.
Oshima T; Sonoda R; Ohkuma M; Sunada H
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1557-62. PubMed ID: 17978511
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]